BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 27581189)

  • 1. Novel Foxp3(-) IL-10(-) Regulatory T-cells Induced by B-Cells Alleviate Intestinal Inflammation in Vivo.
    Shao TY; Hsu LH; Chien CH; Chiang BL
    Sci Rep; 2016 Sep; 6():32415. PubMed ID: 27581189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-12 converts Foxp3+ regulatory T cells to interferon-γ-producing Foxp3+ T cells that inhibit colitis.
    Feng T; Cao AT; Weaver CT; Elson CO; Cong Y
    Gastroenterology; 2011 Jun; 140(7):2031-43. PubMed ID: 21419767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A B-1a cell subset induces Foxp3(-) T cells with regulatory activity through an IL-10-independent pathway.
    Hsu LH; Li KP; Chu KH; Chiang BL
    Cell Mol Immunol; 2015 May; 12(3):354-65. PubMed ID: 25132452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foxp3(+) T cells expressing RORγt represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation.
    Yang BH; Hagemann S; Mamareli P; Lauer U; Hoffmann U; Beckstette M; Föhse L; Prinz I; Pezoldt J; Suerbaum S; Sparwasser T; Hamann A; Floess S; Huehn J; Lochner M
    Mucosal Immunol; 2016 Mar; 9(2):444-57. PubMed ID: 26307665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD101 inhibits the expansion of colitogenic T cells.
    Schey R; Dornhoff H; Baier JL; Purtak M; Opoka R; Koller AK; Atreya R; Rau TT; Daniel C; Amann K; Bogdan C; Mattner J
    Mucosal Immunol; 2016 Sep; 9(5):1205-17. PubMed ID: 26813346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tr1 Cells, but Not Foxp3+ Regulatory T Cells, Suppress NLRP3 Inflammasome Activation via an IL-10-Dependent Mechanism.
    Yao Y; Vent-Schmidt J; McGeough MD; Wong M; Hoffman HM; Steiner TS; Levings MK
    J Immunol; 2015 Jul; 195(2):488-97. PubMed ID: 26056255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor beta induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis.
    Fantini MC; Becker C; Tubbe I; Nikolaev A; Lehr HA; Galle P; Neurath MF
    Gut; 2006 May; 55(5):671-80. PubMed ID: 16162681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid-induced tumor necrosis factor receptor family-related protein regulates CD4(+)T cell-mediated colitis in mice.
    Liao G; Detre C; Berger SB; Engel P; de Waal Malefyt R; Herzog RW; Bhan AK; Terhorst C
    Gastroenterology; 2012 Mar; 142(3):582-591.e8. PubMed ID: 22155173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An IL-27/Lag3 axis enhances Foxp3+ regulatory T cell-suppressive function and therapeutic efficacy.
    Do JS; Visperas A; Sanogo YO; Bechtel JJ; Dvorina N; Kim S; Jang E; Stohlman SA; Shen B; Fairchild RL; Baldwin WM; Vignali DA; Min B
    Mucosal Immunol; 2016 Jan; 9(1):137-45. PubMed ID: 26013006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte-activation gene 3(+) (LAG3(+)) forkhead box protein 3(-) (FOXP3(-)) regulatory T cells induced by B cells alleviates joint inflammation in collagen-induced arthritis.
    Chen SY; Hsu WT; Chen YL; Chien CH; Chiang BL
    J Autoimmun; 2016 Apr; 68():75-85. PubMed ID: 26908164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of RORγt
    Kim BS; Lu H; Ichiyama K; Chen X; Zhang YB; Mistry NA; Tanaka K; Lee YH; Nurieva R; Zhang L; Yang X; Chung Y; Jin W; Chang SH; Dong C
    Cell Rep; 2017 Oct; 21(1):195-207. PubMed ID: 28978473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bifidobacterium infantis attenuates colitis by regulating T cell subset responses.
    Zuo L; Yuan KT; Yu L; Meng QH; Chung PC; Yang DH
    World J Gastroenterol; 2014 Dec; 20(48):18316-29. PubMed ID: 25561798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-presenting cell production of IL-10 inhibits T-helper 1 and 17 cell responses and suppresses colitis in mice.
    Liu B; Tonkonogy SL; Sartor RB
    Gastroenterology; 2011 Aug; 141(2):653-62, 662.e1-4. PubMed ID: 21679711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells.
    Cook L; Stahl M; Han X; Nazli A; MacDonald KN; Wong MQ; Tsai K; Dizzell S; Jacobson K; Bressler B; Kaushic C; Vallance BA; Steiner TS; Levings MK
    Gastroenterology; 2019 Dec; 157(6):1584-1598. PubMed ID: 31513797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KLRG1 expression identifies short-lived Foxp3
    Kornete M; Mason E; Istomine R; Piccirillo CA
    Autoimmunity; 2017 Sep; 50(6):354-362. PubMed ID: 28850267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells.
    Dardalhon V; Awasthi A; Kwon H; Galileos G; Gao W; Sobel RA; Mitsdoerffer M; Strom TB; Elyaman W; Ho IC; Khoury S; Oukka M; Kuchroo VK
    Nat Immunol; 2008 Dec; 9(12):1347-55. PubMed ID: 18997793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells.
    Carter NA; Vasconcellos R; Rosser EC; Tulone C; Muñoz-Suano A; Kamanaka M; Ehrenstein MR; Flavell RA; Mauri C
    J Immunol; 2011 May; 186(10):5569-79. PubMed ID: 21464089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
    Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
    Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
    Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
    J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of Graft-Versus-Host Disease Control Efficacy by Adoptive Transfer of Type 1 Regulatory T Cells in Bone Marrow Transplant Model.
    Jeon YW; Lim JY; Im KI; Kim N; Nam YS; Song YJ; Cho SG
    Stem Cells Dev; 2019 Jan; 28(2):129-140. PubMed ID: 30381994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.